Graham Osborn
Contributor since: 2015
Articles
A Prescription For Teva Shareholders On Actavis Generics
Editors' PickJun. 24, 2016 TEVA, AGN36 Comments
A Valeant Effort: How Allergan Used Acquisition Accounting To Inflate Sales Growth, Boost NOLs, And Reinvent The Operating Profitability Of Actavis Generics
Editors' PickJun. 20, 2016 AGN80 Comments
Actavis Generics: A 2-Year Ticket To Insolvency?
Editors' PickMay 23, 2016 TEVA, AGN61 Comments
A Prescription For Valeant
Nov. 5, 2015 BHC67 Comments
JACK: Thinking Outside The Box
Editors' PickOct. 15, 2015 JACK2 Comments
AmerisourceBergen: Already Been Chewed?
Sep. 23, 2015 ABC4 Comments
Valuing Valeant
Aug. 18, 2015 BHC26 Comments
Historical Comparables For Facebook
Apr. 13, 2015 FB33 Comments